News

Response from the MHRA /FOI

Further to our letter sent on 9 September to Dr June Raine, Interim CEO of the MHRA and to the questions we asked under the Freedom of Information Act, responses have now been received (PDF, 172KB). The medical advisory council of the BMS has reviewed these responses and the following letter was sent to Dr [...]

2019-10-25T15:43:36+01:0025 October 2019|

BMS response to MHRA recommendations

The medical advisory council of the BMS has reviewed the recommendations issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) on 30 August. The following letter was sent to Dr June Raine, interim CEO of the MHRA.

2019-09-09T13:25:30+01:009 September 2019|